Bone Mineral Density, C-Terminal Telopeptide of Type I Collagen, and Osteocalcin as Monitoring Parameters of Bone Remodeling in CML Patients Undergoing Imatinib Therapy: A Basic Science and Clinical Review

Bone Mineral Density, C-Terminal Telopeptide of Type I Collagen, and Osteocalcin as Monitoring Parameters of Bone Remodeling in CML Patients Undergoing Imatinib Therapy: A Basic Science and Clinical Review

Background: Chronic myeloid leukemia (CML) is one of the most commonly found types of myeloproliferative neoplasms, characterized by increased proliferation of granulocytic cells without losing their differentiation ability. Imatinib, a tyrosine kinase inhibitor (TKI), can be effectively used as the...

Full description

Saved in:
Bibliographic Details
Main Authors: Nurita Indarwulan, Merlyna Savitri, Ami Ashariati, Siprianus Ugroseno Yudho Bintoro, Muhammad Noor Diansyah, Putu Niken Ayu Amrita, Pradana Zaky Romadhon
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Diseases
Subjects:
chronic myeloid leukemia
bone mineral density
bone turnover
tyrosine kinase inhibitor
CTX-1
osteocalcin
Online Access:https://www.mdpi.com/2079-9721/12/11/275
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items